前收市價 | 34.38 |
開市 | 35.00 |
買盤 | 35.87 x 100 |
賣出價 | 36.02 x 200 |
今日波幅 | 34.82 - 36.76 |
52 週波幅 | 19.14 - 36.76 |
成交量 | |
平均成交量 | 738,286 |
市值 | 1.511B |
Beta 值 (5 年,每月) | 1.77 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -0.64 |
業績公佈日 | 2024年8月08日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 34.71 |
Short-squeeze stocks represent one of the boldest forms of contrarianism available. Simply put, it’s a showdown between the bears that are attempting to profit from the downturn of a public enterprise. In their minds, by eliminating weak players from the market, it improves Wall Street’s “gene pool,” if you will. On the other end, the bulls can play the savior role. What makes short-squeeze stocks so compelling, though, is the incentivization profile. On the pessimistic side, speculators make th
Aflac, Unum Group and Trupanion have been highlighted in this Industry Outlook article.
Lower claims frequency, moderate pricing and the adoption of technology are likely to boost the performance of Zacks Accident and Health Insurance industry players like AFL, UNM and TRUP.